Fundz

Who to call at Shift Bioscience, and when

Fundz watches for the moments Shift Bioscience starts buying, and tells you who to reach.

  • An alert the day Shift Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shift Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shift Bioscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchShift Bioscience Secures $16 Million to Enhance AI Cell Simulation Platform for Age-Related Disease Treatments

Oct 15, 2024
CambridgeBiotechnologyHealth CareArtificial IntelligenceTherapeuticsMachine Learning

Product Description

Shift Bioscience has raised $16 million in Seed funding to further develop its artificial intelligence cell simulation platform aimed at identifying gene factors that rejuvenate cells and combat age-related illnesses. The funding will accelerate the company's efforts in designing effective drugs for conditions associated with aging.

Company Information

Company

Shift Bioscience

Location

Cambridge, England, United Kingdom

About

Shift Bioscience is a Cambridge-based startup founded in 2017 that is exploring how generative AI models can be utilized to reverse the ageing process by rejuvenating cells. The company aims to address age-related illnesses through cellular reprogramming and has developed an AI cell simulation platform. Their technology seeks to predict gene sets that safely rejuvenate specific cells, tackling conditions like cardiovascular disease and osteoarthritis. Shift Bioscience represents an innovative approach in the biotech sector focused on cell simulation for target discovery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shift Bioscience ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Daniel hidden

hidden

Henry hidden

hidden

Katsiaryna hidden

hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Shift Bioscience's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Shift Bioscience shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.